Like most major retailers, CVS Pharmacy has entered the media business with the intent of broadening and deepening consumer engagement, working with CPG companies to better serve shoppers and grow categories, and establishing a new revenue stream.
When the history of Doug McMillon’s tenure as chief executive officer of Walmart is written, the central theme is sure to be the transformation of the company from one entrenched in brick-and-mortar retailing into a multidimensional enterprise.
as we obviously have — then it’s equally true that this is a new era for the regional chain executive. Explore the National Association of Chain Drug Stores board of directors and you’ll find that it’s well represented,
a great friend of NACDS — stand the
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Former Defense Secretary Donald Rumsfeld once observed that “there are known knowns. There are things we know we know. We also know there are known unknowns.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review.
